James C. Mullen is a businessperson who has been at the helm of 11 different companies and currently occupies the position of Non-Executive Chairman at Percivia LLC, Chairman, President & Chief Executive Officer of Editas Medicine, Inc. and Chief Executive Officer for DPx Holdings BV. He is also on the board of Thermo Fisher Scientific, Inc. and The Rivers School Corp. and Member of Biomedical Sciences Careers Program, Inc. In the past James C. Mullen occupied the position of Executive Chairman at Vicarius Pharma AG, President, Chief Executive Officer & Director at Biogen, Inc. Director at Biogen Idec, Inc. (North Carolina) and President at Biogen Idec New Ventures, Inc. (both are subsidiaries of Biogen, Inc.), Chairman at Torque Therapeutics, Inc., Chief Executive Officer & Non-Independent Director at Patheon, Inc., Chief Executive Officer & Executive Director at Patheon NV, Principal at GlaxoSmithKline LLC and Chairman for Biotechnology Innovation Organization. He received an MBA from Villanova University and an undergraduate degree from Rensselaer Polytechnic Institute.